DexCom

$356.27
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$12.43 (-3.37%) Today
$0.00 (0.00%) As of 12:27 AM UTC after-hours

Why Robinhood?

You can buy or sell DexCom and other stocks, options, and ETFs commission-free!

About DXCM

DexCom, Inc. Common Stock, also called DexCom, is a medical device manufacturing company, which engages in the design, development and commercialization of glucose monitoring systems for ambulatory use by people with diabetes. Its products include Dexcom G6 CGM System, DexCom G6 CGM System for Medicare, Software and Mobile apps. The company was founded by John F. Burd on May 1, 1999 and is headquartered in San Diego, CA. The listed name for DXCM is DexCom, Inc. Common Stock.

CEO
Kevin Ronald Sayer
Employees
6,400
Headquarters
San Diego, California
Founded
1999
Market Cap
34.78B
Price-Earnings Ratio
77.41
Dividend Yield
—
Average Volume
823.65K
High Today
$371.78
Low Today
$352.15
Open Price
$368.49
Volume
1.03M
52 Week High
$456.23
52 Week Low
$182.07

DXCM News

MarketWatch3h

DexCom Inc. stock falls Thursday, underperforms market

Shares of DexCom Inc. DXCM, -3.37% slid 3.37% to $356.27 Thursday, on what proved to be an all-around grim trading session for the stock market, with the S&P 50

DXCM Earnings

$0.00
$0.38
$0.77
$1.15
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
— per share
Actual
Expected Apr 28, After Hours

You May Also Like

ETV
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure